{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:08:16Z","timestamp":1793729296409,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","geriatriconcology.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jgo.2024.101772","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T20:45:43Z","timestamp":1714164343000},"page":"101772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The association between polypharmacy and health-related quality of life among older adults with prostate cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"Zongliang","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2024.101772_bb0005","article-title":"Prostate Cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.jgo.2024.101772_bb0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41391-021-00328-1","article-title":"Treating the patient and not just the cancer: therapeutic burden in prostate cancer","volume":"24","author":"Spratt","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.jgo.2024.101772_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate Cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2024.101772_bb0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/SPC.0000000000000439","article-title":"Multimorbidity in older adults living with and beyond cancer","volume":"13","author":"Corbett","year":"2019","journal-title":"Curr Opin Support Palliat Care"},{"issue":"3","key":"10.1016\/j.jgo.2024.101772_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jgs.15678","article-title":"Multimorbidity and mental health-related quality of life and risk of completed suicide","volume":"67","author":"Wei","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.jgo.2024.101772_bb0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1377\/hlthaff.2018.05273","article-title":"Multimorbidity and health outcomes in older adults in ten European health systems, 2006-15","volume":"38","author":"Palladino","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"11 Suppl Nurse Ed","key":"10.1016\/j.jgo.2024.101772_bb0035","first-page":"11","article-title":"Addressing psychological challenges after cancer: a guide for clinical practice","volume":"22","author":"Recklitis","year":"2008","journal-title":"Oncology (Williston Park)"},{"issue":"3","key":"10.1016\/j.jgo.2024.101772_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/jwas.jwas_140_22","article-title":"Prostate Cancer and challenges in Management in a Semi-urban Centre: a 10-year experience","volume":"12","author":"Okeke","year":"2022","journal-title":"J West Afr Coll Surg"},{"issue":"2","key":"10.1016\/j.jgo.2024.101772_bb0045","first-page":"10154","article-title":"Charlson comorbidity score influence on prostate cancer survival and radiation-related toxicity","volume":"27","author":"Ghanem","year":"2020","journal-title":"Can J Urol"},{"issue":"4","key":"10.1016\/j.jgo.2024.101772_bb0050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41391-022-00550-5","article-title":"Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy","volume":"26","author":"Chen","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.jgo.2024.101772_bb0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41391-021-00328-1","article-title":"Treating the patient and not just the cancer: therapeutic burden in prostate cancer","volume":"24","author":"Spratt","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"10.1016\/j.jgo.2024.101772_bb0060","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1080\/0284186X.2023.2270145","article-title":"Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017","volume":"62","author":"Thomsen","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jgo.2024.101772_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ctrv.2017.03.001","article-title":"The role of drug-drug interactions in prostate cancer treatment: focus on abiraterone acetate\/prednisone and enzalutamide","volume":"55","author":"Del Re","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.jgo.2024.101772_bb0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/17425255.2022.2122812","article-title":"Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug-drug interactions","volume":"18","author":"Conde-Estevez","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"10.1016\/j.jgo.2024.101772_bb0075","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.clgc.2019.05.016","article-title":"Drug-drug interactions in prostate Cancer treatment","volume":"18","author":"Hebenstreit","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"10.1016\/j.jgo.2024.101772_bb0080","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/tox.22403","article-title":"Endocrine-disrupting effects of methylparaben on the adult gerbil prostate","volume":"32","author":"Costa","year":"2017","journal-title":"Environ Toxicol"},{"issue":"8","key":"10.1016\/j.jgo.2024.101772_bb0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11934-018-0812-1","article-title":"The role of testosterone therapy in the setting of prostate Cancer","volume":"19","author":"Rodriguez","year":"2018","journal-title":"Curr Urol Rep"},{"issue":"2","key":"10.1016\/j.jgo.2024.101772_bb0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2217\/fon-2021-0992","article-title":"Medication adherence among patients with advanced prostate cancer using oral therapies","volume":"18","author":"Pilon","year":"2022","journal-title":"Future Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2024.101772_bb0095","first-page":"296","article-title":"Medication adherence, treatment patterns, and dose reduction in patients with metastatic castration-resistant prostate Cancer receiving Abiraterone acetate or enzalutamide","volume":"10","author":"Behl","year":"2017","journal-title":"Am Health Drug Benefits"},{"issue":"1","key":"10.1016\/j.jgo.2024.101772_bb0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/13696998.2022.2066850","article-title":"Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in Canada","volume":"25","author":"Saad","year":"2022","journal-title":"J Med Econ"},{"key":"10.1016\/j.jgo.2024.101772_bb0105","author":"National Cancer Institute"},{"issue":"13","key":"10.1016\/j.jgo.2024.101772_bb0110","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2014.58.7550","article-title":"Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer","volume":"33","author":"Nightingale","year":"2015","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2024.101772_bb0115","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cncr.29119","article-title":"Health-related quality of life in older adult survivors of selected cancers: data from the SEER-MHOS linkage","volume":"121","author":"Kent","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2024.101772_bb0120","unstructured":"National Cancer Institute. Health-related Quality of Life Scale Measure Considerations. Available at https:\/\/healthcaredelivery.cancer.gov\/seer-mhos\/aboutdata\/table.scale.measures.html. Assessed on September 30, 2019."},{"issue":"1","key":"10.1016\/j.jgo.2024.101772_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11136-008-9418-2","article-title":"Population standard for the veterans RAND 12-item health survey (VR-12)","volume":"18","author":"Selim","year":"2009","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jgo.2024.101772_bb0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1081\/COPD-200050663","article-title":"Approaches and recommendations for estimating minimally important differences for health-related quality of life measures","volume":"2","author":"Hays","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.jgo.2024.101772_bb0135","series-title":"StatPearls, StatPearls publishing copyright \u00a9 2023","article-title":"Physiology, body mass index","author":"Zierle-Ghosh","year":"2023"},{"key":"10.1016\/j.jgo.2024.101772_bb0140","unstructured":"U.S. Food and Drug Administration. National Drug Code Directory, Available at https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/national-drug-code-directory. Accessed on April 8, 2023."},{"key":"10.1016\/j.jgo.2024.101772_bb0145","series-title":"The Dangers of Polypharmacy and the Case For Deprescribing in Older Adults. National Institute on Aging","year":"2021"},{"key":"10.1016\/j.jgo.2024.101772_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jclinepi.2022.04.004","article-title":"Geriatric impairments were directly and indirectly associated with mortality in older patients with cancer: a structural equation analysis","volume":"148","author":"Canou\u00ef-Poitrine","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jgo.2024.101772_bb0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12877-023-03852-y","article-title":"Associations between polypharmacy and potentially inappropriate medications with risk of falls among the elderly in Saudi Arabia","volume":"23","author":"AlHarkan","year":"2023","journal-title":"BMC Geriatr"},{"issue":"12","key":"10.1016\/j.jgo.2024.101772_bb0160","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/crj.13434","article-title":"Clinical characteristics and outcomes of polypharmacy in chronic obstructive pulmonary disease patients: a cross-sectional study from Crete, Greece","volume":"15","author":"Ierodiakonou","year":"2021","journal-title":"Clin Respir J"},{"issue":"8","key":"10.1016\/j.jgo.2024.101772_bb0165","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/14740338.2020.1781089","article-title":"Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice","volume":"19","author":"Escudero-Vilaplana","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"10.1016\/j.jgo.2024.101772_bb0170","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1700228","article-title":"Tiotropium in early-stage chronic obstructive pulmonary disease","volume":"377","author":"Zhou","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2024.101772_bb0175","first-page":"2185","article-title":"Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data","volume":"10","author":"Lee","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"10.1016\/j.jgo.2024.101772_bb0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11916-019-0751-7","article-title":"Oxycodone\u2019s unparalleled addictive potential: is it time for a moratorium?","volume":"23","author":"Remillard","year":"2019","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jgo.2024.101772_bb0185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/JPR.S127602","article-title":"Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone\/naltrexone extended-release product","volume":"11","author":"Pergolizzi","year":"2018","journal-title":"J Pain Res"},{"issue":"5","key":"10.1016\/j.jgo.2024.101772_bb0190","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10571-020-01013-y","article-title":"Oxycodone in the opioid epidemic: high \u2018Liking\u2019, \u2018Wanting\u2019, and abuse liability","volume":"41","author":"Kibaly","year":"2021","journal-title":"Cell Mol Neurobiol"},{"issue":"8","key":"10.1016\/j.jgo.2024.101772_bb0195","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00467-021-05358-4","article-title":"Furosemide and albumin for the treatment of nephrotic edema: a systematic review","volume":"37","author":"Hedin","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.jgo.2024.101772_bb0200","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.ajkd.2016.10.022","article-title":"Acetazolamide and hydrochlorothiazide followed by furosemide versus furosemide and hydrochlorothiazide followed by furosemide for the treatment of adults with nephrotic edema: a randomized trial","volume":"69","author":"Fallahzadeh","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.jgo.2024.101772_bb0205","article-title":"Codeine, alone and with paracetamol (acetaminophen), for cancer pain","volume":"2014","author":"Straube","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.jgo.2024.101772_bb0210","first-page":"CD011914","article-title":"Codeine versus placebo for chronic cough in children","volume":"7","author":"Gardiner","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgo.2024.101772_bb0215","series-title":"StatPearls, Treasure Island (FL) Ineligible Companies. Disclosure: Arun Kalava Declares No Relevant Financial Relationships With Ineligible Companies. Disclosure: Kevin King Declares No Relevant Financial Relationships With Ineligible Companies","article-title":"Prescription of controlled substances: Benefits and risks","author":"Preuss","year":"2024"},{"issue":"9","key":"10.1016\/j.jgo.2024.101772_bb0220","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s00125-017-4336-x","article-title":"Metformin: clinical use in type 2 diabetes","volume":"60","author":"Sanchez-Rangel","year":"2017","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.jgo.2024.101772_bb0225","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.119.040144","article-title":"Investigators, metformin use and clinical outcomes among patients with diabetes mellitus with or without heart failure or kidney dysfunction: observations from the SAVOR-TIMI 53 trial","volume":"140","author":"Bergmark","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jgo.2024.101772_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061953","article-title":"Association between Metformin Use and Clinical Outcomes Following Pancreaticoduodenectomy in Patients with Type 2 Diabetes and Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Yoo","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jgo.2024.101772_bb0235","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/jox12020011","article-title":"Vitamin B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes","volume":"12","author":"Farooq","year":"2022","journal-title":"J Xenobiot"},{"issue":"18","key":"10.1016\/j.jgo.2024.101772_bb0240","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1080\/14656566.2018.1538355","article-title":"Efficacy of carbidopa-levodopa extended-release capsules (IPX066) in the treatment of Parkinson disease","volume":"19","author":"Muller","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.jgo.2024.101772_bb0245","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.27338","article-title":"Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease","volume":"33","author":"Fernandez","year":"2018","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.jgo.2024.101772_bb0250","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/pop.2015.0141","article-title":"Association between types of chronic conditions and Cancer stage at diagnosis among elderly Medicare beneficiaries with prostate Cancer","volume":"19","author":"Raval","year":"2016","journal-title":"Popul Health Manag"},{"issue":"1","key":"10.1016\/j.jgo.2024.101772_bb0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.jgo.2024.101772_bb0260","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.119156","article-title":"Full opioid agonists and tramadol: pharmacological and clinical considerations","volume":"11","author":"Edinoff","year":"2021","journal-title":"Anesth Pain Med"},{"issue":"4","key":"10.1016\/j.jgo.2024.101772_bb0265","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol Int"},{"issue":"11","key":"10.1016\/j.jgo.2024.101772_bb0270","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","article-title":"Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies","volume":"91","author":"Markota","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.jgo.2024.101772_bb0275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jgo.2024.101772_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2021.110483","article-title":"The effects of mindfulness-based intervention on sleep disturbance and benzodiazepine hypnotics use in patients hospitalized with cancer: a systematic review and meta-analysis","volume":"146","author":"Yang","year":"2021","journal-title":"J Psychosom Res"},{"issue":"6","key":"10.1016\/j.jgo.2024.101772_bb0285","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jgo.2021.01.009","article-title":"Research priorities to address polypharmacy in older adults with cancer","volume":"12","author":"Nightingale","year":"2021","journal-title":"J Geriatr Oncol"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406824000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406824000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T21:12:25Z","timestamp":1717535545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406824000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1879406824000705"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2024.101772","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between polypharmacy and health-related quality of life among older adults with prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2024.101772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101772"}}